0.395 0.065 (19.7%) | 09-13 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 0.53 | 1-year : | 0.63 |
Resists | First : | 0.46 | Second : | 0.53 |
Pivot price | 0.34 | |||
Supports | First : | 0.35 | Second : | 0.28 |
MAs | MA(5) : | 0.33 | MA(20) : | 0.35 |
MA(100) : | 0.57 | MA(250) : | 0.95 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 51.3 | D(3) : | 36.2 |
RSI | RSI(14): 53.5 | |||
52-week | High : | 2.08 | Low : | 0.28 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ DNMR ] has closed below upper band by 2.1%. Bollinger Bands are 41% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 0.4 - 0.4 | 0.4 - 0.4 |
Low: | 0.33 - 0.33 | 0.33 - 0.33 |
Close: | 0.39 - 0.39 | 0.39 - 0.4 |
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
Thu, 05 Sep 2024
DNMR stock touches 52-week low at $0.32 amid market challenges - Investing.com
Wed, 14 Aug 2024
What Makes Danimer Scientific (DNMR) a New Buy Stock - Yahoo Finance
Thu, 08 Aug 2024
Danimer Scientific, Inc. (DNMR) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Fri, 02 Aug 2024
Danimer Scientific Announces Release Date for Second Quarter 2024 Results - StockTitan
Fri, 24 May 2024
Danimer Scientific faces NYSE non-compliance notice - Investing.com
Tue, 21 May 2024
News Flash: Analysts Just Made A Substantial Upgrade To Their Danimer Scientific, Inc. (NYSE:DNMR) Forecasts - Simply Wall St
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NYSE
|
|
Sector:
Basic Materials
|
|
Industry:
Chemicals - Specialty
|
|
Shares Out | 120 (M) |
Shares Float | 98 (M) |
Held by Insiders | 9.4 (%) |
Held by Institutions | 31 (%) |
Shares Short | 19,820 (K) |
Shares Short P.Month | 20,520 (K) |
EPS | -1.24 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 2 |
Profit Margin | 0 % |
Operating Margin | -246 % |
Return on Assets (ttm) | -8.9 % |
Return on Equity (ttm) | -46 % |
Qtrly Rev. Growth | -40.8 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0.33 |
EBITDA (p.s.) | -0.59 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -58 (M) |
Levered Free Cash Flow | -16 (M) |
PE Ratio | -0.33 |
PEG Ratio | 0 |
Price to Book value | 0.19 |
Price to Sales | 1.19 |
Price to Cash Flow | -0.82 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |